SI1899343T1 - Halogenirani pirazolo a pirimidini postopkiuporabe kot ligand receptorjev GABA A sestavki in intermediati - Google Patents

Halogenirani pirazolo a pirimidini postopkiuporabe kot ligand receptorjev GABA A sestavki in intermediati

Info

Publication number
SI1899343T1
SI1899343T1 SI200630735T SI200630735T SI1899343T1 SI 1899343 T1 SI1899343 T1 SI 1899343T1 SI 200630735 T SI200630735 T SI 200630735T SI 200630735 T SI200630735 T SI 200630735T SI 1899343 T1 SI1899343 T1 SI 1899343T1
Authority
SI
Slovenia
Prior art keywords
åpyrimidines
gaba
intermediates
compositions
processes
Prior art date
Application number
SI200630735T
Other languages
English (en)
Inventor
Luis Anglada
Albert Palomer
Antonio Guglietta
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of SI1899343T1 publication Critical patent/SI1899343T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
    • C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/42—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/43—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SI200630735T 2005-06-21 2006-06-15 Halogenirani pirazolo a pirimidini postopkiuporabe kot ligand receptorjev GABA A sestavki in intermediati SI1899343T1 (sl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69286605P 2005-06-21 2005-06-21
EP05105478A EP1736475A1 (en) 2005-06-21 2005-06-21 Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
PCT/EP2006/063243 WO2006136530A1 (en) 2005-06-21 2006-06-15 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
EP06763737A EP1899343B1 (en) 2005-06-21 2006-06-15 Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates

Publications (1)

Publication Number Publication Date
SI1899343T1 true SI1899343T1 (sl) 2010-09-30

Family

ID=35311853

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630735T SI1899343T1 (sl) 2005-06-21 2006-06-15 Halogenirani pirazolo a pirimidini postopkiuporabe kot ligand receptorjev GABA A sestavki in intermediati

Country Status (25)

Country Link
US (3) US8530482B2 (sl)
EP (2) EP1736475A1 (sl)
JP (1) JP5010591B2 (sl)
KR (1) KR101465802B1 (sl)
CN (1) CN101243089B (sl)
AR (1) AR054785A1 (sl)
AT (1) ATE467635T1 (sl)
AU (1) AU2006261025B2 (sl)
BR (1) BRPI0612075A2 (sl)
CA (1) CA2612726C (sl)
CY (1) CY1111452T1 (sl)
DE (1) DE602006014272D1 (sl)
DK (1) DK1899343T3 (sl)
ES (1) ES2345999T3 (sl)
HK (1) HK1116184A1 (sl)
MX (1) MX2007016340A (sl)
NO (1) NO339973B1 (sl)
PE (1) PE20070071A1 (sl)
PL (1) PL1899343T3 (sl)
PT (1) PT1899343E (sl)
RU (1) RU2478101C2 (sl)
SI (1) SI1899343T1 (sl)
TW (1) TWI382985B (sl)
UY (1) UY29618A1 (sl)
WO (1) WO2006136530A1 (sl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1736475A1 (en) 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates
WO2007109093A2 (en) * 2006-03-17 2007-09-27 Wyeth Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
EP1884516A1 (en) 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions
EP1956021A1 (en) 2006-10-11 2008-08-13 Ferrer Internacional, S.A. Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
EP1918290A1 (en) * 2006-10-11 2008-05-07 Ferrer Internacional, S.A. Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP1921079A1 (en) * 2006-11-08 2008-05-14 Ferrer Internacional, S.A. Amorphous form of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
EP2387557B1 (en) * 2009-01-13 2013-06-19 Interquim, S.A. Process for the preparation of n-[5-(3-dimethylamino-acryloyl)-2-fluoro-phenyl]-n-methyl-acetamide
WO2014163162A1 (ja) 2013-04-04 2014-10-09 武田薬品工業株式会社 複素環化合物
JP2018199623A (ja) * 2015-10-22 2018-12-20 大正製薬株式会社 含窒素縮合複素環化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EP1637533B1 (de) * 2001-03-14 2008-08-13 Grünenthal GmbH Substituierte Thiazolopyrimidine als Analgetika
US20050070555A1 (en) * 2001-12-21 2005-03-31 Bayer Healthcare Ag Aroyl pyridinones
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
WO2006033795A2 (en) * 2004-09-17 2006-03-30 Wyeth Substituted pyrazolo [1, 5-a] pyrimidines for inhibiting abnormal cell growth
WO2006033796A1 (en) * 2004-09-17 2006-03-30 Wyeth SUBSTITUTED PYRAZOLO [1,5-a] PYRIMIDINES AND PROCESS FOR MAKING SAME
CN100528875C (zh) * 2005-02-18 2009-08-19 美德（江西）生物科技有限公司 无结晶型态的印地普隆及其制备方法
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Also Published As

Publication number Publication date
TWI382985B (zh) 2013-01-21
HK1116184A1 (en) 2008-12-19
US20130331401A1 (en) 2013-12-12
EP1736475A1 (en) 2006-12-27
US10072000B2 (en) 2018-09-11
AU2006261025B2 (en) 2011-09-08
TW200726769A (en) 2007-07-16
US20160368912A9 (en) 2016-12-22
RU2478101C2 (ru) 2013-03-27
EP1899343B1 (en) 2010-05-12
CN101243089A (zh) 2008-08-13
PE20070071A1 (es) 2007-02-01
CY1111452T1 (el) 2015-08-05
WO2006136530A1 (en) 2006-12-28
AU2006261025A1 (en) 2006-12-28
CA2612726C (en) 2013-10-01
CN101243089B (zh) 2011-07-06
CA2612726A1 (en) 2006-12-28
MX2007016340A (es) 2008-03-10
JP2008543913A (ja) 2008-12-04
KR20080032104A (ko) 2008-04-14
BRPI0612075A2 (pt) 2010-10-19
DK1899343T3 (da) 2010-09-06
NO20080393L (no) 2008-03-10
EP1899343A1 (en) 2008-03-19
UY29618A1 (es) 2006-10-31
PT1899343E (pt) 2010-08-17
US20130331610A1 (en) 2013-12-12
US20090111848A1 (en) 2009-04-30
RU2008101371A (ru) 2009-07-27
AR054785A1 (es) 2007-07-18
NO339973B1 (no) 2017-02-27
PL1899343T3 (pl) 2010-10-29
ATE467635T1 (de) 2010-05-15
US8530482B2 (en) 2013-09-10
ES2345999T3 (es) 2010-10-07
DE602006014272D1 (de) 2010-06-24
JP5010591B2 (ja) 2012-08-29
KR101465802B1 (ko) 2014-11-27

Similar Documents

Publication Publication Date Title
EP1734820A4 (en) Imidazopyrrazine, imidazopyridine, and imidazo-pyrimidine as CRF1 receptor ligands
SI1899343T1 (sl) Halogenirani pirazolo a pirimidini postopkiuporabe kot ligand receptorjev GABA A sestavki in intermediati
SI1904494T1 (sl) Imidazo(1,2-a)piridin spojine kot inhibitorji vegf-r2
ZA200606615B (en) Heteroaryl-fused pyrazolo derivatives
EP1928237A4 (en) NEW HETEROCYCLES BASED ON IMIDAZO
IL206466A0 (en) PYRAZOLO [1,5-a]PYRIMIDINES, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF
ZA200706734B (en) Pyrazolopyrimidines
IL177510A0 (en) Pyrazolopyrimidines
PL2217578T3 (pl) Związki [1,2,4]triazolo[1,5-a]pirydyny i [1,2,4]triazolo[1,5-c]pirymidyny i ich zastosowanie
ZA200705279B (en) Processes for preparing pyrazolo[3,4-d]pyrimidine ethers
EP1863483A4 (en) Bicyclic pyrazole compounds as anti-bacteriostatic agents
IL195238A0 (en) Pyrazolo [1,5-a]pyrimidines as cdk inhibitors
HK1106719A1 (en) Multi-purpose bio-material composition
ZA200804335B (en) Substituted bicyclic pyrimidone derivatives
EP1737313A4 (en) MOVABLE ARMREST
IL192056A0 (en) Antibacterial pyrrolopyridines, pyrrolopyrimidines, and pyrroloazepines
EP2142542A4 (en) NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704
PL1926476T3 (pl) Amorficzne stałe dyspersje 7-chloro-N,N,5-trimetylo-4-okso-3-fenylo-3,5-dihydro-4H-pirydazyno[4,5-b]indolo-1-acetamidu
BRPI0822239A2 (pt) Composto de pirazolo[1,5-a] pirimidina
EP1773833A4 (en) PYRROLO (OXO) CHINOLINE AS 5HT LIGANDS
EP1914109A4 (en) AUTO SLIDING SEAT
HK1120803A1 (en) Pyrazolo
IL202471A0 (en) Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands
IL185340A0 (en) Nod1 as an anti-tumor agent
GB2433993B (en) Single molecule TR-FRET probe